My Cart

DM-1

DM-1 Product List

  • Product Category

    Antibody (4)

  • Product Status

    Launched (4)

  • Species

    Mouse (3)Rabbit (1)

  • Tag

    Mouse IgG1 (3)- (1)

  • Conjugate

    Unconjugated (2)HRP Labeled (1)Biotin-labeled (1)

DM-1 Background

Mertansine (DM-1) is a tubulin inhibitor that binds to the ends of microtubules and inhibits microtubule dynamics. DM-1(Mertansine) has antitumor activity and functions as a regulator of tubulin. It is an alpha-amino acid ester, a carbamate, an epoxide, an organic heterocyclic tetracyclic compound, an organochlorine compound, a mercaptan, and a maydenin alkaloid. DM-1, derived from Mydenin, is a cytotoxic component of antibody-drug conjugations that produce antibody-drug conjugations via a sulfhydryl group splice with SPP (n-succinimide 4- (2-pyridyl dithio)) or SMCC (4- (3-mercapto-2, 5-dioxy-1 pyrrolidyl) -cyclohexanic acid) splice.

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
Delpacibart eteddesiranAOC-1001; AOC 1001Phase 3 ClinicalAvidity Biosciences IncMyotonic Disorders; Genetic Diseases, Inborn; Musculoskeletal Diseases; Muscular Disorders, Atrophic; Myotonic Dystrophy; Muscular Atrophy; Heredodegenerative Disorders, Nervous System; Muscular Diseases; Neuromuscular Diseases; Nervous System Diseases; Muscular Dystrophies; Neurodegenerative Diseases; Myotonia
Details
Dyne-101Dyne101Phase 2 ClinicalDyne Therapeutics IncMyotonic Dystrophy
Details
ARO-DM1ARO-DM1Phase 2 ClinicalArrowhead Pharmaceuticals IncMyotonic Dystrophy
Details
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland